Medical management of acutely recurring pterygium with topical mitomycin-C
| Autor: | Francisco A. Folgar, Rohit S. Adyanthaya, Esen K. Akpek |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Adult
Male Alkylating Agents medicine.medical_specialty Pterygium excision Administration Topical Mitomycin Treatment outcome Pterygium Recurrence medicine Humans Prospective Studies Prospective cohort study High rate business.industry Mitomycin C Treatment options Middle Aged medicine.disease Sensory Systems Surgery Ophthalmology Treatment Outcome Acute Disease Female business |
| Zdroj: | Journal of Cataract and Refractive Surgery. 35:200-202 |
| ISSN: | 0886-3350 |
| Popis: | One of the major limitations of pterygium excision is the high rate of postoperative recurrence. Preoperative, intraoperative, or postoperative use of mitomycin-C (MMC) remains the most commonly used medical adjunctive therapy to prevent recurrence. However, once the recurrence occurs, reexcision is the only treatment option. We used topical MMC to treat acutely recurring pterygia without reexcision. The study included 4 patients who had a primary pterygium excision using amniotic membrane graft or conjunctival autograft without the use of MMC at the time of initial surgery and later developed a clinically significant, grade 4 recurrence (Figures 1 and 2), based on the classification described by Prabhasawat et al. Demographic features and clinical findings in the patient are shown in Table 1. Recurrence was |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|